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Purpose: Investigate the genotype-phenotype correlations for five TGFBI (transforming growth factor, beta-induced)
mutations  including  one  novel  pathogenic  variant  and  one  complex  allele  affecting  the  fourth  FAS1  domain  of
keratoepithelin, and their potential effects on the protein’s structure.
Methods: Three unrelated families were clinically diagnosed with lattice corneal dystrophy (CD) and one with an
unclassified CD of Bowman’s layer. Mutations in the TGFBI gene were detected by direct sequencing, and the functional
impact of each variant was predicted using in silico algorithms. Corneal phenotypes, including histological examinations,
were compared with the literature data. Furthermore, molecular modeling studies of these mutations were performed.
Results: Two distinct missense mutations affecting the same residue at position 509 of keratoepithelin: p.Leu509Pro (c.
1526T>C) and p.Leu509Arg (c.1526T>G) were found to be associated with a lattice-type CD. The novel p.Val613Gly
(c.1828T>G) TGFBI mutation was found in a sporadic case of an Algerian individual affected by lattice CD. Finally, the
Bowman’s layer CD was linked to the association in cis of the p.Met502Val and p.Arg555Gln variants, leading to the
reclassification of this CD as atypical Thiel-Behnke CD. Structural modeling of these TGFBI mutations argues in favor
of these mutations being responsible for instability and/or incorrect folding of keratoepithelin, predictions that are
compatible with the clinical diagnoses.
Conclusions: Description of a novel TGFBI mutation and a complex TGFBI allele further extends the mutational spectrum
of TGFBI. Moreover, we show convincing evidence that TGFBI mutations affecting Leu509 are linked to the lattice
phenotype in two unrelated French families, contrasting with findings previously reported. The p.Leu509Pro was reported
to be associated with both amyloid and non-amyloid aggregates, whereas p.Leu509Arg has been described as being
responsible for Epithelial Basement Membrane Dystrophy (EBMD).
Several clinical forms of autosomal dominant corneal
dystrophies (CDs) are caused by missense mutations in the
human transforming growth factor β-induced gene (TGFBI;
OMIM  *601692)  that  codes  an  ubiquitous  68  kDa
extracellular matrix protein named keratoepithelin (KE) [1,
2]. Depending on the TGFBI mutation, the entire mutated KE,
or its proteolytic fragments, accumulate in the corneal stroma
with distinct ultrastructures forming amyloid (Lattice Corneal
Dystrophies;  LCD),  rod-shaped  crystalloid  structures
(Granular CD type 1 and Reis-Bucklers CD), a combination
of amyloid and rod-shaped bodies (Granular CD type 2), or
“curly fibers” (Thiel-Behnke CD) [3,4]. The accumulation of
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KE aggregates in the different CD forms occurs at different
locations  within  the  corneal  stroma  and  leads  to  corneal
clouding and visual impairment with varying degrees severity.
The current treatments for TGFBI corneal dystrophies are
penetrating  keratoplasty  or  excimer  laser  phototherapeutic
keratectomy, both of which usually restore vision in affected
patients [3,5]. Until now, more than 40 TGFBI mutations have
been described in many different countries, and have been
shown to affect either one of the two mutational hot spot
residues Arg124 and Arg555, or to be clustered in the fourth
fasciculin-like domain 4 (FAS1–4) of KE corresponding to
amino acids 502–632 [3,6]. All genetic analysis worldwide
has  highlighted  a  remarkable  genotype-phenotype
correlation, allowing a better clinical-molecular classification
of this group of diseases. Now, while the insight offered by
these  findings  remains  valuable,  the  genotype-phenotype
correlation of these corneal dystrophies has gradually gained
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1192in  complexity;  it  has  been  well  demonstrated  that  some
TGFBI  mutations  have  shown  significant  phenotypic
variability.
The  precise  function  of  keratoepithelin  is  still  not
elucidated, but this protein contains four homologous tandem
repeat domains of 140 amino acids known as FAS1 domains,
which  are  similar  to  those  found  in  fasciculin  I,  a
Drosophilia neuronal adhesion molecule [7]. FAS1 domains
are  known  to  mediate  cell  adhesion  and  migration  by
interacting with diverse matrix proteins such as fibronectin,
collagen,  laminin,  proteoglycans,  and  also  with  specific
integrins  [8-10].  The  KE  protein  fourth  FAS1  domain’s
structure is available in the protein data bank (PDB). The
NMR (Nuclear Magnetic Resonance) structures are stored
under 1X3B PDB ID and a recently released crystal structure
under 2VXP PDB ID. There are no significant differences
between the structures determined using both methods. The
structure of keratoepithelin consists of a seven-stranded β
wedge and several α helices in a novel arrangement, which
bears no similarities to any other domain of known structures
[7,11].
In this study, we report the phenotype of four distinct
TGFBI mutations affecting the fourth FAS1 domain. They
include a novel TGFBI mutation, p.Val613Gly, the allelic
association of p.Arg555Gln and p.Met502Val mutations, and
two TGFBI variants affecting the same residue, p.Leu509Pro
and p.Leu509Arg. The p.Leu509Pro variant has previously
been  reported  in  one  German  family  with  a  geographic
pattern-like clinical phenotype associated with both hyaline
and amyloid stromal deposits. In contrast, the p.Leu509Arg
variant was detected in one French family and diagnosed as
an Epithelial Basement Membrane Dystrophy (EBMD) [12,
13].  In  our  two,  four-generation  French  families  with
autosomal  dominant  dystrophy,  we  found  that  Leu509
variants both segregated, with geographic opacities seen at the
level of Bowman’s layer and with lattice lines in the deeper
layers of the corneal stroma, consistent with a diagnosis of
lattice-type  corneal  dystrophy.  Histologic  examinations  of
diseased  p.Leu509Pro  corneas  in  our  French  patients
demonstrated that all deposits were amyloid, in contrast to the
two types reported for the German family, being amyloid and
granular [13]. This report therefore provides further evidence
of  ongoing  complexities  concerning  the  pathogenesis  and
classification  of  TGFBI  corneal  dystrophies.  Finally,  our
structural modeling allows us to present the predicted effects
of  the  four  different  TGFBI  mutations  outlined  above,
providing insight into their disease mechanisms.
METHODS
Patients:  We  analyzed  three  families  (A,  B,  and  C),  one
isolated case (case D), and a subset of four patients with
EBMD. All subjects underwent clinical examinations (visual
acuity, slit lamp biomicroscopy) in an ophthalmology unit and
histopathologic  records  were  reviewed  on  a  case-by-case
basis. The pedigree of each family was established and all
were consistent with a dominant autosomal transmission of
the  corneal  disease.  All  of  the  four  rare  or  new  TGFBI
mutations  (p.Leu509Pro,  p.Leu509Arg,  p.Val613Gly,  and
p.Met502Val) identified in the patients reported here have
been screened in control subjects using direct sequencing of
the corresponding TGFBI exons to determine whether they
were  polymorphims  or  disease-mutations.  The  control
population consisted of 100 unrelated French individuals who
showed  normal  corneal  appearance  after  slit-lamp
biomicroscopy  examination.  Additionally,  our  study  also
enrolled more than 60 French families affected with TGFBI
corneal dystrophies, which were sent to our laboratory for
mutations  screening.  The  Algerian  control  population
included a set of 100 unrelated, unaffected individuals who,
according to medical records, had no family history of corneal
disease.
Molecular  analysis:  Blood  samples  were  collected  from
patients for DNA analysis. Written informed consent was
obtained from all the individuals who participated in the study.
Genomic  DNA  was  extracted  from  peripheral  blood
lymphocytes using a standard phenol/chloroform extraction
procedure. PCR amplification of exons 4 to 17 and flanking
splice sites of the TGFBI gene was achieved (primers used are
presented  in  Table  1),  and  all  amplicons  were  directly
sequenced  on  both  strands  according  to  the  protocols
accompanying  the  BigDye  Terminator  v3.0  Cycle
Sequencing  Kit  (Applied  Biosystem-Life  Technologies,
Courtaboeuf,  France).  An  ABI  PRISM®  3130xl  DNA
Sequencer  (Applied  Biosystems)  was  used  to  collect  the
sequence data. Sequences were aligned and compared with
the  reference  TGFBI  genomic  sequence  (GenBank
NM_000358.1) using the SeqScape software v2.5 (Applied
Biosystems).
Histologic examination: The available corneal buttons were
bisected immediately after grafting. Each button was fixed in
Bouin's solution and was processed for evaluation. Corneal
sections were stained with hematoxylin and eosin, periodic
acid-Schiff, Alcian blue, Masson's trichrome, red Congo, and
thioflavinT.
In silico analysis by SIFT, PolyPhen, SNPs3D, and PMut:
Bioinformatics  approaches  were  used  to  identify  highly
conserved  areas  of  a  gene  through  a  multiple  sequence
alignment  analysis  across  numerous  species  or  related
proteins, and thereafter, to predict the potential impact of a
residue in addition to structural data. These programs take into
account, to varying degrees, physico-chemical properties of
proteins (a change in charge or in the hydrophobicity, or a
helix-breaking  propensity),  and  their  three-dimensional
structures. Different algorithms (SIFT, PolyPhen, SNPs3D,
and  PMut)  were  used  to  evaluate  the  possible  functional
impact  of  the  keratoepithelin  amino  acid  substitutions
identified here.
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1193Molecular  modeling:  The  protein  structure  used  in  the
modeling  part  is  the  keratoepithelin  protein  fourth  FAS1
domain NMR structure, which is deposited in the protein data
bank (PDB) under code 1x3b. The structure with the most
favorable ANOLEA score was selected from the 20 deposited
was selected and used to perform the subsequent calculations
[14]. The importance of the amino acid side chains in certain
positions, and the influence of the mutations in these positions
on the structural stability were studied using computational
alanine scanning. The software used for this purpose was
FoldX 2.5.1 [15].The procedure was as follows: in a protein
model,  residues  of  interest  were  mutated  to  alanine  by
replacing their side chains with methyl groups and the folding
free energy, also referred to as the stability, of the resulting
mutants was compared to that of the wild type protein. The
folding free energy is the difference in free Gibbs energy
between the folded and unfolded states for a given sequence.
The result thus estimates the influence of a given residue side
chain on the stability of the protein. To study the influence of
Gly substitution on the Val613 position in greater detail, we
performed a 10 ns-long molecular dynamics (MD) simulation
of the wild type NMR structure and of the NMR structure with
the Val613Gly mutation. The mutation was introduced using
Chimera software [15]. The MD simulation was conducted in
the CHARMM force field using the GROMACS molecular
dynamics package (Department of Biophysical Chemistry,
University of Groningen, The Netherlands) in a water box
with periodic boundary conditions [16,17]. After a steepest
descent minimization and 1 ns-long equilibration, the 10 ns-
long simulation was performed at 300 K for both the wild type
and p.Val613Gly structures. The folding free energies were
calculated  using  the  FoldX  2.5.1  program  for  100
conformations regularly extracted from the MD simulation
(one every 100 ps).
RESULTS
Clinical phenotypes:
Family A—This family was clinically evaluated in the
Department of Ophthalmology at Besançon Hospital. The
proband was a French woman born in 1961 (individual III.1,
Figure 1A), who was first examined at age 20 for a giant
epithelial ulcer of the right cornea that was initially diagnosed
TABLE 1. PRIMER SEQUENCES USED FOR AMPLIFICATION OF TGFBI.
Exon Primer name Primer sequence Melting temperature Product size (bp)
4 TGFBI-4F cctcgtcctctccacctgta 60 328
  TGFBI-4R tcggggaagtaaggcagttc 61  
5 TGFBI-5F gtctgcagcccctaactgac 60 317
  TGFBI-5R cacaaagagggtgggttgtc 60  
6 TGFBI-6F gcttgtggaacccacatttt 60 392
  TGFBI-6R tcaggggaacctgctctatg 60  
7 TGFBI-7F tgggtttggcttctgttttc 60 376
  TGFBI-7R catggcaggtggtatgttca 60  
8 TGFBI-8F gggtcctcatctgagagaacag 60 480
  TGFBI-8R gtcacaacccacacatttgc 60  
9 TGFBI-9F cgagatgacattcctgctga 60 369
  TGFBI-9R ttttggttgagctgagtgga 59  
10 TGFBI-10F tccaaactcaaggagggatg 60 365
  TGFBI-10R tcagcaaccagttctcatgc 60  
11 TGFBI-11F tgaccctgctacatgctctg 60 374
  TGFBI-11R ccatcccaagtctggaaggt 61  
12 TGFBI-12F cctctcagcgtggtgaggta 61 261
  TGFBI-12R ggccctgagggatcactact 60  
13 TGFBI-13F gggcagggagttcttcattt 60 351
  TGFBI-13R gctgcaacttgaaggttgtg 60  
14 TGFBI-14F ctgggcgacaagattgaaac 61 433
  TGFBI-14R tgtggtgcattcaaaaccaa 61  
15 TGFBI-15F ggaaatgtgagccagaaagc 60 284
  TGFBI-15R agcagccaaggaagacagg 60  
16 TGFBI-16F accttccccttcctcttcct 60 281
  TGFBI-16R caaaggccaggcttctttta 60  
17 TGFBI-17F ttggccctggtccttgag 62 250
  TGFBI-17R gcggcccatgtacattaaa 59  
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1194as EBMD. However, slit-lamp examination revealed bilateral
subepithelial opacities that appeared geographic in shape and
that were combined with stromal fine lattice lines (Figure 1B).
Over the ensuing years, this proband complained of recurrent
episodes of epithelial erosions with pain and photophobia, and
her visual acuity progressively declined because of corneal
opacification. She underwent penetrating keratoplasty at age
33 on her right eye, and at age 36 on her left eye, and the
corneal  buttons  were  examined  histopathologically.  On
histological examination, specimens from both eyes exhibited
irregular  epithelial  thickening  associated  with  focal
interruption of the Bowman layer, secondary to the presence
of  amorphous  eosinophilic  linear  deposits.  Additional
eosinophilic round aggregates, which were small in size, were
observed  randomly  spread  within  the  anterior  and  mild
corneal stroma. These eosinophilic deposits did not stain red
with Masson trichrome, but all stained orange with Congo red
and  displayed  apple-green  birefringence  under  polarized
light, characteristic of amyloid aggregates (Figure 1C). The
endothelium and Descemet’s membrane appeared normal. In
this  family,  a  total  of  six  affected  patients  over  three
generations showed similar corneal phenotypes; such as onset
in the second decade; recurrent corneal erosions with severe
corneal  ulceration;  and  the  requirement  for  corneal
transplantation  with  amyloid  recurrence  following
penetrating keratoplasty (pedigree in Figure 1A). Histological
examination  of  corneal  buttons  from  three  different
individuals  in  this  family  also  showed  similar
Figure 1. Family A. A: Pedigree showing a four-generation family affected by lattice-type corneal dystrophy. Open and closed symbols indicate
unaffected and affected individuals, respectively, arrows indicate the proband in each family, and asterisks indicate members who were
examined clinically and genetically. A bar on top of a symbol indicates that patients had received a bilateral grafted in both eyes. Diagonal
lines indicate deceased individuals. B: Retroillumination slit-lamp view of patient IV-1 at 21 years of age. The left eye contained a network
of thick lattice lines (arrowhead) and dots. C: Congo red positive deposits of amyloid aggregates are found in subepithelial (fine arrow) and
mild corneal stroma (arrowhead). Green birefringence is visible with a polarizing ﬁlter. Stromal deposition of amyloid substance distorts the
architecture of corneal lamellae. D: The electropherogram of exon 11 of the TGFBI gene is shown. The proband III.1 has a heterozygous
thymine to cytosine change at codon 509 in exon 11 (c.1526T>C, p.Leu509Pro).
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1195histopathological features consisting of amyloid deposits (not
illustrated). Furthermore, we did not detect an intraepithelial
cysts, which are suggestive of EBMD.
Family B—This family was clinically evaluated in the
Department of Ophthalmology at Tours Hospital. The index
patient (IV.4) was a 41-year-old man from a French family in
which  several  members,  spanning  four  consecutive
generations,  were  clinically  affected  with  a  very  similar
clinical course and consistently presented with painful corneal
erosions  with  geographic  opacities  seen  at  the  level  of
Bowman’s layer (Figure 2A). The patient IV.4 complained,
from the age of 25 years, of repetitive episodes of corneal
erosions initially only affecting the right eye. The seizure
frequency  gradually  increased,  and  epithelial  erosions
progressively affected both eyes and were accompanied by
pain and visual deterioration that lead to rapidly penetrating
keratoplasty. At this initial stage, the diagnosis was herpes
keratitis  although  laboratory  investigations  for  corneal
infection including Herpesviridae were always negative. Slit-
lamp  examination  revealed  bilateral  map  geographic-like
opacities in the sub-epithelium with lattice lines within the
corneal stroma (Figure 2B). To date, no corneal material from
this patient or from other affected family members has been
available for histological examination.
Family C—This family has been clinically evaluated in
the Department of Ophthalmology at Montpellier Hospital.
This third French family included five affected individuals
over four generations, all of whom presented with a similar
corneal disease with autosomal dominant inheritance (Figure
3A). For all affected patients, the onset of the disease began
in the first decade of life with unexplained chronic keratitis
and conjunctivitis. The patients complained of the sensation
of foreign bodies in the eye together with pain, redness, and
severe photophobia, and they presented with opacities at the
Figure 2. Family B. A: Pedigree of this family with an atypical lattice corneal dystrophy. B: Slit-lamp examination revealed bilateral map
geographic-like opacities in the sub-epithelium with lattice lines (arrowhead) within the corneal stroma in the 41-year-old man (IV.4). C:
Electropherograms of exon 11 of TGFBI gene. The proband IV.4, showing a heterozygous thymine to guanine change at codon 509 (c.
1526T>G, p.Leu509Arg).
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1196level  of  Bowman’s  layer  leading  to  progressive  visual
impairment between the 4th and 5th decades of life. At the
time of diagnosis, the proband (patient III.1) was a 49-year-
old  man  who  had  been  managed  since  childhood  for
unexplained chronic keratitis and conjunctivitis leading to
progressive decreased visual acuity (a visual acuity of 1/10 in
the right eye and 3/10 in the left eye). A slit lamp examination
of both eyes revealed an irregular epithelial thickening with
multiple subepithelial and stromal dot-shaped non-coalescent
opacities localized to the central cornea (Figure 3B). Lens
examination showed a phacosclerosis in both eyes. His 21-
year-old daughter (IV.1) exhibited identical findings in both
corneas and had also had keratitis and conjunctivitis from the
age of 14 months, together with severe photophobia (Figure
3C). Slit-lamp examination revealed multiple dot-shaped and
diffuse  opacities  confined  to  the  sub-epithelial  area  and
without any fluorescein-stained regions (Figure 3C). Family
members  did  not  show  any  clinically  evident  lattice-type
lesions, and the corneal opacities involved only the superficial
stromal  layers  of  the  cornea.  No  family  member  has
undergone corneal transplantation, therefore the nature of the
deposits associated with the corneal dystrophy could not be
determined.  The  ophthalmologists  confirmed  a  clinical
diagnosis of Bowman’s layer CD but its subtype could not be
ascertained because the clinical features did not meet the
diagnostic classification of either Reis-Bucklers CD or Thiel-
Benhke CD. Therefore, this corneal dystrophy did not receive
a  specific  initial  clinical  diagnosis  and  was  classified  as
atypical Bowman’s CD. Further, based on the results of the
molecular analysis, this corneal dystrophy was reclassified as
atypical Thiel-Benhke CD, although the confirmation of the
presence of curly fibers on TEM is missing.
Case D—The patient was an Algerian male, born in 1925,
who was referred, at the age of 80, for evaluation of bilateral
Figure 3. Family C. A: Pedigree of the family C included five affected individuals, spanning four generations, with an atypical Thiel-Behnke
CD. B: The proband (III.1) at 49 years of age; irregular epithelial thickening with multiple subepithelial and stromal dot-shaped non-coalescent
opacities are shown (arrowhead). C: The affected individual IV.1 at 21 years of age; slit-lamp examination revealed multiple dot-shaped (fine
arrow) and diffuse opacities only in the sub-epithelial area. D: Electropherograms of exon 11 and 12 of the TGFBI gene are shown. The
proband IV.1 has a complex allele composed of a novel change p.Met502Val (c.1504A>G in exon 11) and p.Arg555Gln (c.1664G>A in exon
12). E: Partial amino acid sequence alignment of keratoepithelin for comparison among eleven species.
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1197corneal dystrophy to the Hotel-Dieu Hospital in Paris (Figure
4A). A corneal graft of the right eye was performed and on
histological  examination  numerous  findings  suggested  a
lattice type corneal dystrophy. The majority of the cornea
epithelium was abraded; the Bowman's layer was slightly
wrinkled at the anterior corneal surface. The stroma appeared
slightly thickened and contained eosinophilic deposits. These
aggregates  did  not  take  up  Masson's  trichrome  stain  but
showed positive staining with Congo red and thioflavin-T.
This patient has 12 children but little clinical information is
available on them, except for one child born in 1954, who has
been monitored in Algeria and who has exhibited small dots
and a star-shaped opacity.
TGFBI sequence analysis and prediction analysis: In Family
A,  TGFBI  screening  showed  a  c.1526T>C  heterozygous
nucleotide substitution in exon 11 that modified the leucine at
codon  509  to  proline:  p.Leu509Pro  (Figure  1D).  This
mutation, which was detected in five affected individuals but
not  in  five  healthy  family  members,  suggests  that
p.Leu509Pro is highly likely to be a disease-causing mutation.
Moreover,  this  TGFBI  mutation  was  not  detected  in  the
ethnically matched controls tested in our study (see Methods).
In Family B, all three affected members (III.3, IV.4, and IV.
5) were found to be heterozygous for a c.1526T>G change at
exon 11, predicted to result in the substitution of leucine for
arginine  at  codon  509:  p.Leu509Arg  (Figure  2C).  This
mutation was not detected in the unaffected individual (III.1),
nor  in  the  ethnically  matched  control  individuals.  All
bioinformatics algorithms showed that leucine 509 is highly
conserved across several animal species (e.g., mice, chickens,
chimpanzees, and dogs) as well as in the human protein,
periostin; predicting that mutations at this position would be
expected to adversely affect the function or structure of the
encoded protein.
In  Family  C,  TGFBI  sequence  analysis  in  affected
individuals  (II.1,  II.3,  III.1,  and  IV.1)  revealed  two
Figure 4. Case D at 80 years of age. A: Representative images of corneal opacities (arrowhead) seen in the right eye of case D, at 80 years of
age. B: Electropherograms around the codon 613 in exon 14 of the TGFBI gene. The patient is heterozygous for a novel mutation, thymine
to guanine substitution at position 1828 (c. 1828T>G), causing the p.Val613Gly amino acid exchange. C: Partial amino acid sequence
alignment of keratoepithelin with ten of its orthologs. The boxes indicate valine at position 613 in the human protein.
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1198heterozygous nucleotide changes that cosegregated with the
corneal disease. The first nucleotide variation is a base pair
change in exon 11 at nucleotide position 1504 (A→G), which
converts  a  methionine  at  codon  502  into  a  valine:
p.Met502Val  (Figure  3D).  The  second  nucleotide  change
affects  exon  12  of  TGFBI,  and  corresponds  to  the
p.Arg555Gln pathogenic mutation classically associated with
Thiel-Behnke CD. Family segregation analysis showed that
both  p.Met502Val  and  p.Arg555Gln  TGFBI  variants  are
present in four affected family members (II.1, II.3, III.1, and
IV.1) spanning three generations, supporting therefore that
these  two  variants  are  in  allelic  association  on  the  same
deleterious chromosome (Figure 3A). Mutational screening
of  the  p.Met502Val  mutation  in  our  ethnically  matched
French control population did not detect this variant. In silico
analysis predicted the p.Met502Val as being most probably a
tolerant  variant.  We  further  examined  evolutionary
conservation of the methionine residue at position 502 using
multiple  TGFBI  protein  sequence  alignments.  The  data
indicated that Met502 is strictly conserved in mice, rats, pigs,
macaques, chimpanzees, and dogs but is replaced by threonine
in frogs and chicken, serine in rabbits, or glutamine residue in
zebrafish (Figure 3E).
In case D, a novel disease-causing nucleotide change was
identified in the heterozygous state at exon 14: c.1828T>G,
leading to the substitution of valine for glycine at codon 613
(p.Val613Gly;  Figure  4B).  Further  screening  showed  two
additional variants in the heterozygous state, p.Leu472Leu
and  c.1804–35C>T,  which  were  previously  identified  as
polymorphisms (rs1133170 and rs45626931, respectively).
Unfortunately, family segregation of this novel variant could
not be performed since the patient’s family members were not
available. However, this TGFBI mutation was absent in 200
chromosomes from the ethnically matched Algerian control
individuals. The conservation level of residue Val at position
613  is  high:  it  is  conserved  in  domains  3  and  4  of  the
homologous protein fasciclin I in Drosophila melanogaster
and  is  also  highly  conserved  across  species  (Figure  4C).
SIFT, PolyPhen, SNPs3D, and PMut algorithms predicted that
the mutation p.Val613Gly is a deleterious substitution causing
an alteration in protein structure or function.
Computational  alanine  scanning:  We  performed  a
computational alanine scan on the keratoepithelin structure
using the FoldX 2.5.1 program to examine the importance of
Met502, Leu509, Arg555, and Val613 side chains for protein
stability. A decrease in the protein stability was observed for
Leu509 and Val613 upon mutation to alanine of 3.25 kcal/mol
and 1.84 kcal/mol, respectively. This observation confirms the
importance of the presence of both residues for the structural
stability of keratoepithelin and suggests plausible support for
the destabilizing effect of Leu509 and Val613 mutations. In
contrast, the mutation to alanine resulted in an increase in
structural stability by 0.58 kcal/mol for position 502 and a
non-significant decrease of structural stability by 0.3 kcal/mol
for position 555. Indeed, both residues, Met502 and Arg555,
are solvent-exposed and are therefore not crucial to protein
stability.
Molecular dynamics of wild type keratoepithelin protein and
its p.Val613Gly variant: MD simulations in explicit solvent
were  performed  for  the  wild  type  NMR  structure  of
keratoepithelin and its p.Val613Gly mutant. The geometry
analysis shows that during the 10 ns of MD simulation, the
wild type protein was only slightly more stable than the mutant
protein. The averaged root mean square deviation (RMSD)
from the starting structure, calculated for the backbone atoms,
was  1.4  Å  for  the  wild  type  protein  and  1.7  Å  for  the
p.Val613Gly  mutant.  The  folding  free  energy  of  100
simulation frames revealed, however, a significant difference
in molecule stability during the simulation. The mean folding
free  energy  value  of  the  wild  type  keratoepithelin
conformation was 3.1 kcal/mol lower than the average value
for the Val613Gly mutant, according to FoldX 2.5.1 program
calculations.
NMR  structure  of  the  FAS1  domain  4  of  keratoepithelin:
According to the NMR structure of the fourth domain FAS1
of keratoepithelin, the Leu509 residue is located in the NH2-
terminal αL helix. Its side chain points toward the interior of
the protein and interacts with the hydrophobic side chains of
Ala541  and  Val519  (Figure  5A).  The  other  neighboring
residues of Leu509 are Val505, Met506, Val508, Leu518,
Ile522, and Val625. The aberrant presence of a polar arginine
side  chain  at  this  position  is  incompatible  with  the
hydrophobic character of the surrounding residues and with
the tight packing of their side chains, hence probably leading
to the incorrect folding of this domain. The Met502 is located
at  the  linker  region  between  the  FAS1  third  and  fourth
domains and outside the compact protein core (Figure 5B).
We presume that the fragment is solvent-exposed and that
mutation to residues more hydrophobic than methionine, such
as  valine,  can  affect  protein  folding.  Furthermore,  the
methionine amino acid residue contains a sulfur atom, which
is susceptible to oxidation and is slightly more bulky. The
residue Arg555 is located at the solvent exposed α4 helix, on
the other side of FAS1 domain 4 of the keratoepithelin protein
and the potential interaction of Met502Val and Arg555Gln
residues can therefore be excluded (Figure 5B). The Val613
residue is situated on the β6 strand and contributes to the
hydrophobic core formed by the β5, β7, and β6 strands. The
side  chain  of  this  residue  is  in  contact  with  the  Val606,
Val608, and Pro616 side chains (Figure 5C). This observation
suggests that residue Val613 has structural importance. The
substitution to glycine at this position creates a cavity within
the densely packed hydrophobic interior of the protein, which
probably influences protein stability.
DISCUSSION
Molecular TGFBI gene screening of three unrelated French
families with autosomal CD and one isolated case of Algerian
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1199origin identified four different mutations, including a novel
pathogenic  variant  and  a  complex  TGFBI  allele.  The
remaining TGFBI variants that we report on correspond to two
distinct  missense  mutations  affecting  the  same  residue  at
position  509  of  keratoepithelin:  p.Leu509Pro  and
p.Leu509Arg. We show that both Leu509 variants of TGFBI
cause  corneal  dystrophy  of  the  lattice  type.  These  two
TGFBI variants have previously been described on only one
occasion in separate studies and have been associated with
different clinical diagnoses [12,13].
The  Leu509  variants:  The  p.Leu509Pro  variant  has
previously been reported in a German family having a Reis-
Bucklers-like  CD,  which  was  clinically  characterized  by
opacities with geographic patterns in the subepithelium and
the  anterior  stroma  [13].  Although  no  lattice  lines  were
evident from slit-lamp examination, both amyloid and non-
amyloid aggregates were found in the affected corneas in this
family. The phenotype in our patients with the p.Leu509Pro
variant includes similar opacities that appear geographic in
shape in the superficial layer, but which are associated with
fine and discrete lattice lines in the deeper stromal layers.
Histopathology  showed  that  all  deposits  were  amyloid  in
nature, and the disease was classified as a lattice CD. The two
families  previously  described  as  having  the  p.Leu509Pro
variant,  exhibited  a  corneal  phenotype  characterized  by
amyloid subepithelial and stromal opacities and inconstant
formation  of  non  amyloid  deposits.  We  have  no  clear
explanations for this histopathological variability between the
two families, but previous reports also described variability in
phenotypes concerning the mutation of p.Gly623Asp, which
has been associated with LCD type I/IIIA, Reis-Bucklers CD
and atypical CD [18,19]. It remains a possibility that non-
amyloid  deposits  could  have  been  missed  in  our  patients
because  they  could  be  masked  by  amyloid  aggregates,
alternatively they also could occur later in the course of the
disease. However, three corneal buttons from different family
members of differing ages were examined and all showed
similar histopathological features with only amyloid deposits.
The p.Leu509Arg variant identified in our second French
family is associated with clinical features that are very similar
to  those  presented  by  our  patients  suffering  with  the
p.Leu509Pro mutation, including painful corneal erosions in
the second decade of life and geographic opacities at the level
of Bowman’s membrane with lattice lines in the deeper layers
of the stroma. Although deposits of amyloid material could
not be demonstrated on histologic examination of diseased
corneas with p.Leu509Arg, the presence of lattice lines at the
biomicroscopic  level  is  highly  suggestive  of  lattice  type
corneal dystrophy. This clinical diagnosis therefore differs
from that reported by Boutboul et al. for the p.Leu509Arg
variant in another French family with EBMD [12]. Ambiguity
in the diagnosis of patients with TGFBI p.Leu509Arg variant
could result from the interpretation of corneal erosions at a
stage where lattice lines are not easily detectable during slit-
lamp examination. No corneal specimen was available for the
family  carrying  the  p.Leu509Arg  variant  reported  by
Boutboul et al. [12] to determine whether amyloid aggregates
were detected or not. Nine TGFBI mutations in this domain
are amyloidogenic, and three leucine residues located close to
Leu509 (Leu518, Leu527, Leu569), mutated to arginine or
Figure  5.  Local  structure  around  the
mutated residue in the fourth domain of
the keratoepithelin protein (1x3b PDB
code). The protein is shown in cartoon
representation. Leu509 (A), Met502 and
Arg555 residues (B), Val613 (C) and
the neighboring residues are shown in
stick  representation  in  red  and  gray,
respectively.
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1200proline, have been described in families with various forms of
LCDs [20-23]. The structural importance of the Leucine 509
of keratoepithelin is confirmed here by computational alanine
scanning data, which revealed that the mutation of this residue
to alanine causes a decrease in the stability of more than 3
kcal/mol. In view of the fact that protein stability, measured
as the free energy difference between the folded and unfolded
states, has a value typically ranging between 5 and 15 kcal/
mol for small proteins, the loss of stability is remarkable
[24]. This information argues in favor of amyloid formation
for mutations affecting leucine 509 residue, and we think that
patients with p.Leu509Arg mutation of TGFBI should not be
classified as EBMD, but rather as having a lattice form of
corneal dystrophy. In families A and B, no microcysts in the
corneal  epithelium  were  detected.  We  also  investigated  a
small set of patients who were diagnosed as having EBMD,
but in whom no pathogenic mutation in the TGFBI gene was
found. It could be noted that our patients with both of the
Leu509 TGFBI mutations had painful and recurrent epithelial
erosions that were sometimes complicated by severe corneal
ulcers. Although recurrent corneal erosions are a common
finding in various forms of TGFBI CDs, such atypical and
severe clinical presentation, which predominates the clinical
picture  for  several  years  before  the  lattice  lines  become
clinically evident, may lead to incorrect diagnoses of EBMD
or herpes keratitis being made.
The p.Val613Gly variant: We have identified a novel
mutation, p.Val613Gly, associated with a corneal dystrophy
of  the  lattice  type.  Although  familial  segregation  of
p.Val613Gly could not be assessed, different findings support
that p.Val613Gly is pathogenic. With respect to the structure
of keratoepithelin, we showed that the Val613 residue is of
structural importance. The computational alanine scanning
and the molecular dynamics simulation of the p.Val613Gly
mutant compared to the wild type protein show a decrease in
the protein stability compatible for protein aggregation, which
is the physiopathology underlying molecular mechanism that
characterize CDs linked to TGFBI. The mutation to glycine
might also lead to improper folding in view of the fact that the
glycine backbone structure is not restricted by the presence of
a side chain and can adopt any conformation which might lead
to misfolding. The p.Val613Gly mutation may also facilitate
the β-pleated sheet structure favoring the accumulation of
insoluble  protein  material  and  amyloid  formation.  In
agreement  with  the  predicted  dramatic  effect  of  the
p.Val613Gly mutation, is the presence of amyloid deposits
from corneas of case D.
[p.Met502Val;p.Arg555Gln] variants: In Family C, we
have  identified  a  complex  TGFBI  allele
[p.Met502Val;p.Arg555Gln]  associated  with  a  corneal
dystrophy of an unspecified type. These two heterozygous
nucleotide changes in exon 11 and exon 12 are present in all
affected family members and are predicted to change two
residues in the FAS1 domain 4 of the keratoepithelin, where
the TGFBI disease-causing mutations are clustered. The status
of the p.Met502Val variant is questionable in terms of its
ability to determine whether it is a neutral or an intolerant
variant. Numerous points argue in favor of its pathogenicity.
First, in 2009, Zenteno et al. [25] identified the p.Met502Val
variant as the disease-causing mutation in a Mexican family.
Second, this variant was exclusively found in affected patients
and was completely absent from ethnic Mexican and French
control subjects. Additionally, p.Met502Val variant has not
been  registered  in  the  Single  Nucleotide  Polymorphism
(SNP) database. Third, we note that even if the degree of
conservation of Met502 among TGFBI orthologs is moderate,
a valine residue at this amino acid position is never found in
any species. Fourth, the p.Met502Val variant is predicted to
affect  the  folding  of  keratoepithelin.  Fifth,  this  region  of
TGFBI  has  been  previously  associated  with  numerous
disease-causing mutations [12,13,26,27]. Based on all of these
assessments, the p.Met502Val variant is highly likely to be a
disease-causing mutation. However, two major unresolved
questions  remain  to  be  elucidated.  First,  it  would  be  of
importance to define the characteristic features of corneal
deposits associated with the p.Met502Val variant, and second,
to determine the potential phenotypic modifier effect of the
p.Met502Val variant over the p.Arg555Gln variant. Indeed,
we have previously shown that the association in cis of both
the  p.R124L  and  delT125-E126  variants  gives  rise  to  a
specific granular corneal phenotype, resulting most probably
from the effect of each molecular defect [28].
In  conclusion,  this  study  highlights  how  phenotype-
genotype  correlations  in  TGFBI  CDs  may  be  particularly
complex,  making  the  availability  of  combined
histopathological and genetic data necessary for the better
classification  of  these  corneal  dystrophies.  Furthermore,
identification of the p.Leu509Arg in a French family with
lattice-type corneal dystrophy raises the need to reconsider the
role  of  TGFBI  in  the  molecular  diagnosis  of  Epithelial
basement membrane dystrophy (EBMD).
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